Options - Schedule of Options Outstanding and Exercisable (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Options outstanding (in shares) | 2,584,791 | 2,620,813 | |
| Weighted Average Exercise Price | $ 20.06 | $ 20.06 | $ 19.38 |
| Options Exercisable (in shares) | 782,537 | ||
| Weighted Average Exercise Price Exercisable (in dollars per share) | $ 7.04 | ||
| Employee Stock Option | |||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Options outstanding (in shares) | 2,584,791 | ||
| Range of Exercise Price, Lower (in dollars per share) | $ 0.67 | 2.35 | |
| Range of Exercise Price, Upper (in dollars per share) | $ 40 | $ 40 | |
| Weighted Average Remaining Contractual Life (Year) | 7 years 6 months 7 days | 8 years 4 months 6 days | |
| Weighted Average Exercise Price | $ 20.44 | $ 20.06 | |
| Options Exercisable (in shares) | 782,537 | 552,856 | |
| Weighted Average Exercise Price Exercisable (in dollars per share) | $ 7.04 | $ 6.56 | |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|